Cyclerion regains compliance with Nasdaq minimum bid price requirement

Cyclerion Therapeutics, Inc.

Received formal notice from Nasdaq of regained compliance with $1.00 minimum bid price rule.
Non-compliance notice received June 1, 2022; compliance achieved after 10 consecutive trading days ending May 30, 2023.
Stock will continue to be listed and traded on the Nasdaq Capital Market; matter is closed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.